High Tech Pharm Co., Ltd. (KOSDAQ:106190)

South Korea flag South Korea · Delayed Price · Currency is KRW
12,790
-230 (-1.77%)
Last updated: Oct 10, 2025, 2:26 PM KST
-1.77%
Market Cap138.44B
Revenue (ttm)74.65B
Net Income (ttm)10.56B
Shares Out10.63M
EPS (ttm)991.66
PE Ratio13.13
Forward PEn/a
Dividend100.00 (0.77%)
Ex-Dividend DateDec 27, 2024
Volume23,853
Average Volume33,399
Open13,020
Previous Close13,020
Day's Range12,730 - 13,020
52-Week Range11,130 - 16,590
Beta0.80
RSI45.40
Earnings DateNov 12, 2025

About High Tech Pharm

High Tech Pharm Co., Ltd. researches and develops, manufactures, and sells injectable carbapenem-based antibiotics worldwide. The company was incorporated in 1998 and is based in Chungju-si, South Korea. [Read more]

Industry Pharmaceutical Preparations
Founded 1998
Employees 65
Stock Exchange KOSDAQ
Ticker Symbol 106190
Full Company Profile

Financial Performance

In 2024, High Tech Pharm's revenue was 77.51 billion, an increase of 0.97% compared to the previous year's 76.77 billion. Earnings were 13.71 billion, an increase of 69.75%.

Financial Statements

News

There is no news available yet.